UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Aug 30, 2024

Keywords

ClinConnect Summary

The clinical trial titled "UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS" is focused on learning more about rare types of gynecological cancers, specifically uterine sarcomas, vulvar cancer, and non-epithelial ovarian cancers. These cancers are often not well studied, which can lead to challenges in diagnosing and treating them effectively. The goal of this trial is to gather detailed information on these diseases to improve patient management and outcomes. A team of experts from various fields will work together to collect and analyze samples and data, helping to create better strategies for diagnosis and treatment based on the specific characteristics of these cancers.

To be eligible to participate in this trial, individuals must be over 18 years old and have a confirmed diagnosis of one of the targeted cancers. Participants can expect to contribute to important research that could lead to improved clinical guidelines and personalized treatment options. It's important to note that individuals with certain active infections or other types of gynecological cancers may not qualify. This trial is not yet recruiting participants, but it represents a significant step toward enhancing the understanding and management of rare gynecological cancers.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • \>18 years old
• Histological diagnosis of:
• • Non-epithelial ovarian tumors Uterine sarcomas Vulvar cancer
• Exclusion Criteria:
• • Active HIV, HBV, or HCV infection Synchronous neoplasms Non-rare histologies of gynecological malignancies